AT282064B - Verfahren zur Herstellung von neuen, pharmazeutisch verwendbaren Ferrihydroxyd-Komplexen - Google Patents
Verfahren zur Herstellung von neuen, pharmazeutisch verwendbaren Ferrihydroxyd-KomplexenInfo
- Publication number
- AT282064B AT282064B AT940267A AT940267A AT282064B AT 282064 B AT282064 B AT 282064B AT 940267 A AT940267 A AT 940267A AT 940267 A AT940267 A AT 940267A AT 282064 B AT282064 B AT 282064B
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- new
- pharmaceutically acceptable
- ferric hydroxide
- hydroxide complexes
- Prior art date
Links
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical class [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/18—Oxidised starch
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4746666 | 1966-10-22 | ||
| GB5732366 | 1966-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT282064B true AT282064B (de) | 1970-06-10 |
Family
ID=26266056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT940267A AT282064B (de) | 1966-10-22 | 1967-10-18 | Verfahren zur Herstellung von neuen, pharmazeutisch verwendbaren Ferrihydroxyd-Komplexen |
Country Status (1)
| Country | Link |
|---|---|
| AT (1) | AT282064B (de) |
-
1967
- 1967-10-18 AT AT940267A patent/AT282064B/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT280996B (de) | Verfahren zur Herstellung von neuen 1-Hydroxyphenyl-2-aminoalkanolen | |
| AT301037B (de) | Verfahren zur Herstellung von neuen 3-OA-11β-OB-13β-C-17α-R-17β-OE-gona-1,3,5(10)-trienen | |
| CH484049A (de) | Verfahren zur Herstellung von neuen Hydroxycyclohexylaminen | |
| AT272343B (de) | Verfahren zur Herstellung von neuen 2-Cycloalkylamino-oxazolinen | |
| AT281836B (de) | Verfahren zur Herstellung von neuen 2-Methyl-3-carbonsäureamido-chinoxalin-di-N-oxiden-(1,4) | |
| CH478828A (de) | Verfahren zur Herstellung von neuen substituierten 3,1-Benzoxazin-2-onen | |
| CH496022A (de) | Verfahren zur Herstellung von neuen N,N'-Diglycidyl-Verbindungen | |
| AT277282B (de) | Verfahren zur Herstellung von neuen N,N'-Diglycidyl-bis-hydantoinyl-verbindungen | |
| AT281838B (de) | Verfahren zur Herstellung von neuen 2-Isothiuronium-methyl-3-carbonsäureamido-chinoxalin-di-N-oxid-(1,4)-halogeniden | |
| AT275758B (de) | Verfahren zur Herstellung von neuen 4-Oxa-9β,10α-Steroiden | |
| AT272527B (de) | Verfahren zur Herstellung von neuen Derivaten des Proscillaridin A | |
| CH487887A (de) | Verfahren zur Herstellung von neuen 1-Aryl-3-alkylaminopyrrolidinen | |
| AT283356B (de) | Verfahren zur Herstellung von neuen 1,2,4-Oxdiazolidin-Derivaten | |
| CH471782A (de) | Verfahren zur Herstellung eines neuen, substituierten 2,3-Pyridindiols | |
| AT272369B (de) | Verfahren zur Herstellung von neuen 6-Amino-uracil-5-carbonamid-N-sulfonamiden | |
| AT282064B (de) | Verfahren zur Herstellung von neuen, pharmazeutisch verwendbaren Ferrihydroxyd-Komplexen | |
| AT287936B (de) | Verfahren zur herstellung von neuen 22-amino-23,24-bisnorcholanderivaten | |
| CH482727A (de) | Verfahren zur Herstellung von neuen Phosphinylimiden | |
| CH521361A (de) | Verfahren zur Herstellung von neuen 11-Amino-5,6-dihydro-6-morphanthridonen | |
| AT281020B (de) | Verfahren zur Herstellung von neuen 3-Imino-1,2-benzisothiazolinen | |
| CH522619A (de) | Verfahren zur Herstellung von neuen Derivaten von 2a,3a-Epithioandrostanen | |
| AT291967B (de) | Verfahren zur Herstellung von neuen N-Phenyl-N-2-fluor-1,1,2,2,-tetrachloräthylsulfenyl-sulfamiden | |
| AT277186B (de) | Verfahren zur Herstellung von neuen Trihalogenäthylglycinaten | |
| CH487114A (de) | Verfahren zur Herstellung von neuen 1-Amino-3-aryloxypropan-2-äthern | |
| AT281837B (de) | Verfahren zur Herstellung von neuen 3-Carbonsäureamido-chinoxalin-di-N-oxiden-(1,4) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELA | Expired due to lapse of time |